Last reviewed · How we verify
diabetic kidney disease
Approved treatments
- olmesartan medoxomil-hydrochlorothiazide · Cosette
Olmesartan works by blocking the action of a hormone that causes blood vessels to constrict, allowing blood vessels to relax and blood pressure to decrease. - Lisinopril/HCTZ · Direct_Rx
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- diabetic kidney disease patent landscape — cliff calendar, originator estates, attackable patents
- diabetic kidney disease treatment landscape brief
- diabetic kidney disease treatment updates RSS
Frequently asked questions about diabetic kidney disease
What drugs treat diabetic kidney disease?
Tracked treatments include olmesartan medoxomil-hydrochlorothiazide, Lisinopril/HCTZ.
What is the treatment for diabetic kidney disease?
Standard treatment for diabetic kidney disease includes olmesartan medoxomil-hydrochlorothiazide, Lisinopril/HCTZ. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: diabetic kidney disease patent cliff · diabetic kidney disease CI report
- Treatment: olmesartan medoxomil-hydrochlorothiazide · Cosette
- Treatment: Lisinopril/HCTZ · Direct_Rx
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing